Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9Recurrence 5Neoplasm Metastasis 4Lymphoma, T-Cell, Peripheral 4Lymphoma, T-Cell 3Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell 2Lymphoma 2Lung Neoplasms 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Smoking 1Polycystic Ovary Syndrome 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Papillomavirus Infections 1Papilloma 1Ovarian Neoplasms 1Neoplasms 1Lymphoma, Primary Cutaneous Anaplastic Large Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Leukemia 1Laryngeal Diseases 1Infertility 1Immunoblastic Lymphadenopathy 1

Interventions

epigallocatechin gallate 1Vitamin B 12 1Sugars 1Papanicolaou Test 1Maltose 1Interferon-alpha 1Hyaluronic Acid 1Human Papillomavirus DNA Tests 1Folic Acid 1Colposcopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Papilloma × Folic Acid × Clear all
NCT05625308 2022-12-22

Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions

Lo.Li.Pharma s.r.l

Phase NA Completed
40 enrolled

Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡